Pharmacological interventions for smoking cessation: an overview and network meta-analysis.

@article{Cahill2013PharmacologicalIF,
  title={Pharmacological interventions for smoking cessation: an overview and network meta-analysis.},
  author={Kate Cahill and Sarah Stevens and Rafael Perera and Tim Lancaster},
  journal={The Cochrane database of systematic reviews},
  year={2013},
  volume={5},
  pages={
          CD009329
        }
}
BACKGROUND Smoking is the leading preventable cause of illness and premature death worldwide. Some medications have been proven to help people to quit, with three licensed for this purpose in Europe and the USA: nicotine replacement therapy (NRT), bupropion, and varenicline. Cytisine (a treatment pharmacologically similar to varenicline) is also licensed for use in Russia and some of the former socialist economy countries. Other therapies, including nortriptyline, have also been tested for… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 439 CITATIONS, ESTIMATED 46% COVERAGE

Cost-effectiveness of enhancing a Quit-and-Win smoking cessation program for college students

VIEW 8 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Real-world effectiveness of varenicline versus nicotine replacement therapy in patients with and without psychiatric disorders.

VIEW 8 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED

Role of nicotine receptor partial agonists in tobacco cessation

VIEW 7 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Current advances in research in treatment and recovery: Nicotine addiction

VIEW 30 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2012
2020

CITATION STATISTICS

  • 45 Highly Influenced Citations

  • Averaged 76 Citations per year from 2017 through 2019

References

Publications referenced by this paper.
SHOWING 1-6 OF 6 REFERENCES

Personal communication August

  • B. Shea
  • 2011
VIEW 2 EXCERPTS

Correction. Canadian Medical Association Journal 2008;179(8):802

  • MJ Eisenberg, KB Filion
  • 2008